LENZ Therapeutics, Inc. (LENZ) EPS (Basic) (2022 - 2023)
LENZ Therapeutics (LENZ) has disclosed EPS (Basic) for 2 consecutive years, with -$18.62 as the latest value for Q4 2023.
- On a quarterly basis, EPS (Basic) fell 4230.23% to -$18.62 in Q4 2023 year-over-year; TTM through Dec 2023 was -$35.71, a 1840.76% decrease, with the full-year FY2024 number at -$2.34, up 93.45% from a year prior.
- EPS (Basic) was -$18.62 for Q4 2023 at LENZ Therapeutics, down from -$9.62 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.43 in Q4 2022 to a low of -$18.62 in Q4 2023.